| Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963–1995: recent increase in cervical cancer incidence A Anttila, E Pukkala, B Söderman, M Kallio, P Nieminen, M Hakama International journal of cancer 83 (1), 59-65, 1999 | 363 | 1999 |
| Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis K Tainio, A Athanasiou, KAO Tikkinen, R Aaltonen, J Cárdenas, ... bmj 360, 2018 | 348 | 2018 |
| Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis M Arbyn, CWE Redman, F Verdoodt, M Kyrgiou, M Tzafetas, ... The Lancet Oncology 18 (12), 1665-1679, 2017 | 328 | 2017 |
| Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting M Leinonen, P Nieminen, L Kotaniemi-Talonen, N Malila, J Tarkkanen, ... JNCI: Journal of the National Cancer Institute 101 (23), 1612-1623, 2009 | 322 | 2009 |
| Gynaecological infections as risk determinants of subsequent cervical neoplasia M Viikki Acta Oncologica 39 (1), 71-75, 2000 | 274 | 2000 |
| The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri P Nieminen, M Kallio, M Hakama Obstetrics & Gynecology 85 (6), 1017-1021, 1995 | 268 | 1995 |
| European guidelines for clinical management of abnormal cervical cytology, part 2 J Jordan, P Martin‐Hirsch, M Arbyn, U Schenck, JJ Baldauf, D Da Silva, ... Cytopathology 20 (1), 5-16, 2009 | 242 | 2009 |
| Identification of a nonsense mutation in the PAX9 gene in molar oligodontia P Nieminen, S Arte, D Tanner, L Paulin, S Alaluusua, I Thesleff, S Pirinen European Journal of Human Genetics 9 (10), 743-746, 2001 | 241 | 2001 |
| European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1 J Jordan, M Arbyn, P Martin‐Hirsch, U Schenck, JJ Baldauf, D Da Silva, ... Cytopathology 19 (6), 342-354, 2008 | 232 | 2008 |
| Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised … A Anttila, L Kotaniemi-Talonen, M Leinonen, M Hakama, P Laurila, ... Bmj 340, 2010 | 230 | 2010 |
| Organised vs. spontaneous pap‐smear screening for cervical cancer: A case‐control study P Nieminen, M Kallio, A Anttila, M Hakama International journal of cancer 83 (1), 55-58, 1999 | 224 | 1999 |
| Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study I Kalliala, A Anttila, E Pukkala, P Nieminen Bmj 331 (7526), 1183-1185, 2005 | 208 | 2005 |
| Self-sample HPV tests as an intervention for nonattendees of cervical cancer screening in Finland: a randomized trial A Virtanen, P Nieminen, T Luostarinen, A Anttila Cancer epidemiology, biomarkers & prevention 20 (9), 1960-1969, 2011 | 165 | 2011 |
| European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid‐based cytology M Arbyn, A Herbert, U Schenck, P Nieminen, J Jordan, E McGoogan, ... Cytopathology 18 (3), 133-139, 2007 | 149 | 2007 |
| Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting L Kotaniemi-Talonen, P Nieminen, A Anttila, M Hakama British journal of cancer 93 (8), 862-867, 2005 | 145 | 2005 |
| Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction A Iwasawa, P Nieminen, M Lehtinen, J Paavonen Cancer: Interdisciplinary International Journal of the American Cancer …, 1996 | 134 | 1996 |
| Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature I Kalliala, A Athanasiou, AA Veroniki, G Salanti, O Efthimiou, N Raftis, ... Annals of oncology 31 (2), 213-227, 2020 | 130 | 2020 |
| Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland MK Leinonen, P Nieminen, S Lönnberg, N Malila, M Hakama, A Pokhrel, ... Bmj 345, 2012 | 128 | 2012 |
| Cervical cancer screening programme in Finland A Anttila, P Nieminen European Journal of Cancer 36 (17), 2209-2214, 2000 | 127 | 2000 |
| Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized … M Lehtinen, C Lagheden, T Luostarinen, T Eriksson, D Apter, K Harjula, ... BMJ open 7 (8), e015867, 2017 | 112 | 2017 |
